REVANESSE Trademark

Trademark Overview

On Thursday, February 7, 2019, a trademark application was filed for REVANESSE with the United States Patent and Trademark Office. The USPTO has given the REVANESSE trademark a serial number of 88293145. The federal status of this trademark filing is REGISTERED as of Tuesday, June 2, 2020. This trademark is owned by Prollenium Medical Technologies, Inc.. The REVANESSE trademark is filed in the Pharmaceutical Products category with the following description:

Syringes containing hyaluronic acid gel for use in cosmetic treatment procedures and wound healing
revanesse

General Information

Serial Number88293145
Word MarkREVANESSE
Filing DateThursday, February 7, 2019
Status700 - REGISTERED
Status DateTuesday, June 2, 2020
Registration Number6066727
Registration DateTuesday, June 2, 2020
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 17, 2020

Trademark Statements

Description of MarkThe mark consists of the word "REVANESSE" in stylized font.
Goods and ServicesSyringes containing hyaluronic acid gel for use in cosmetic treatment procedures and wound healing
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 8, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameProllenium Medical Technologies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAurora, Ontario L4G4C3
CA
Party NameProllenium Medical Technologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAurora, Ontario L4G4C3
CA
Party NameProllenium Medical Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAurora, Ontario L4G4C3
CA

Trademark Events

Event DateEvent Description
Thursday, May 2, 2019PRIORITY ACTION WRITTEN
Monday, February 11, 2019NEW APPLICATION ENTERED
Friday, March 1, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 19, 2019ASSIGNED TO EXAMINER
Thursday, May 2, 2019PRIORITY ACTION E-MAILED
Thursday, May 2, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, May 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 7, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 8, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 18, 2019SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, January 13, 2020SUSPENSION INQUIRY WRITTEN
Monday, January 13, 2020INQUIRY TO SUSPENSION E-MAILED
Monday, January 13, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, January 17, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, May 13, 2019SUSPENSION LETTER WRITTEN
Monday, May 13, 2019LETTER OF SUSPENSION E-MAILED
Monday, May 13, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, December 13, 2019ASSIGNED TO LIE
Monday, February 10, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, February 10, 2020EXAMINERS AMENDMENT E-MAILED
Monday, February 10, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 10, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, February 11, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 26, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 17, 2020PUBLISHED FOR OPPOSITION
Tuesday, March 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 2, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, January 24, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, January 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 21, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 2, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

revanesse procedures wound healing treatment cosmetic containing hyaluronic acid syringes